VitaNova Life Sciences (VNOV) Net Income towards Common Stockholders Growth (3y) (2020 - 2026)
VitaNova Life Sciences (VNOV) Net Income towards Common Stockholders Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 56.12% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 1.17% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -85.30% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -9.14% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 48.09% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -82.72% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | -21.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -21.76% |
| Oct 31, 2025 | 139.67% |
| Jul 31, 2025 | -187.23% |
| Apr 30, 2025 | 217.00% |
| Jan 31, 2025 | 101.52% |
| Oct 31, 2024 | 29.57% |
| Jul 31, 2024 | -33.65% |
| Apr 30, 2024 | 104.63% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -29.18% |
| Jul 31, 2022 | 27.56% |
| Oct 31, 2021 | 35.16% |
| Jul 31, 2021 | 209.34% |
| Jul 31, 2020 | -36.17% |